Skip navigation
fda/cms summit: 4-5 december 2008, washington

About Us

By combining access to relevant expert opinion gained by our investigative financial reporters, with the analytical depth of sell-side investment bank research, our unique approach delivers real insights to our clients on the most price sensitive events in the pharmaceutical market from an independent perspective.

History

Pharmawire was founded in July 2007 by the publishers of Debtwire and dealReporter, well established global services in the credit and event-driven M&A markets. The business is now owned by the Financial Times Group, publisher of the Financial Times newspaper and FT.com.

How to Subscribe

If you would like to subscribe to the Pharmawire service or would like to inquire about a trial, please contact:

Americas

Eileen Creighton
Tel: +1 212-500-1384
eileen.creighton@pharmawire.com

Europe

Natasha Brooks
Tel: +44 (0)20 7059 6202
natasha.brooks@pharmawire.com